Who
Scott Gottlieb
Director
Company insider
Files Form 4 as: Director, UnitedHealth Group; Director, Tempus AI; Director, Illumina; Director, Pfizer; Director, CombiMatrix; Director, Targeted Medical Pharma; Director, Molecular Insight Pharmaceuticals.
In numbers
- Trades disclosed
- 73
- Buys
- 11
- Sells
- 2
- Bought
- $476K
- Sold
- $2.7M
- Companies
- 7
- Companies where not an officer
- 7
- First trade
- 12 May 2009
- Last trade
- 1 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 5 Oct 2026 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —257 at $0.00 | filing |
| 22 Sep 2026filed 24 Sep 2026 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —5 at $0.00 | filing |
| 22 Sep 2026filed 24 Sep 2026 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —5 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —210 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —210 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —3 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —3 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Code A | —5,913 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | TEM Tempus AIIT Services & Consulting | SEC FORM 4 Code A | —5,913 at $0.00 | filing |
| 21 May 2026filed 22 May 2026 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | $300K2,072 at $144.83 | filing |
| 21 May 2026filed 22 May 2026 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | $300K2,072 at $144.83 | filing |
| 23 Apr 2026filed 27 Apr 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K7,686.539 at $26.67 | filing |
| 23 Apr 2026filed 27 Apr 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K7,686.54 at $26.67 | filing |
| 1 Apr 2026filed 6 Apr 2026 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —320 at $0.00 | filing |
| 1 Apr 2026filed 6 Apr 2026 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —320 at $0.00 | filing |
| 17 Mar 2026filed 19 Mar 2026 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —1 at $0.00 | filing |
| 17 Mar 2026filed 19 Mar 2026 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —1 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | ILMN IlluminaLife-science tools | SEC FORM 4 Bought | $24K200 at $117.81 | filing |
| 9 Feb 2026filed 11 Feb 2026 | ILMN IlluminaLife-science tools | SEC FORM 4 Bought | $24K200 at $117.81 | filing |
| 2 Jan 2026filed 6 Jan 2026 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —125 at $0.00 | filing |
News
Illumina To Webcast Upcoming Investor ConferenceILMN · prnewswire.com · 20 Oct 2026Illumina's (ILMN) Sequencing Business Is Recovering, But Is the Stock Getting Ahead of Itself?ILMN · insidermonkey.com · 13 Oct 2026Illumina (NASDAQ:ILMN) Stock Price Expected to Rise, Royal Bank Of Canada Analyst SaysILMN · themarketsdaily.com · 7 Oct 2026
0 headlines in the last 90 days name Scott Gottlieb; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.